CoreWeave (NASDAQ:CRWV) is trading at $107.73, well below the $178 price target Cantor Fitzgerald just reiterated on the AI cloud specialist. That gap works out to roughly 65% of implied upside from current levels.
CoreWeave rents NVIDIA GPU capacity to AI labs, hyperscalers, and enterprises building large models. Since its March 2025 Nasdaq listing, the stock has become a proxy for AI infrastructure buildout. Q2 2026 revenue reached $2.58 billion, up 112.3% year over year, and revenue backlog swelled to roughly $104 billion.
Analysts, led by Cantor’s Brett Knoblauch, are using the latest results to push numbers higher. The market has moved, but not enough to close the dislocation.
A Post-IPO Drawdown the Earnings Spike Only Partially Fixed
CoreWeave’s slide began with a Q1 2026 report in early May. Revenue beat consensus, but GAAP EPS of -$1.40 missed by 16.26%, and shares that had traded at $136.80 at filing began declining. Over the trailing year the stock has fallen 27.58%, badly lagging the S&P 500.
Headwinds included a Q4 2025 securities fraud class action alleging concealed data center construction delays, interest expense of $640 million last quarter versus $267 million a year ago, free cash flow of -$5.74 billion, and widening GAAP net loss of $626 million.
Q2 2026 landed on August 11. Shares spiked from $87.64 to $107.73, a 22.9% one-day gain. Even after that jump, the stock is still down 3.22% over the trailing three months.
Why Cantor’s $178 Target Hasn’t Budged Lower
Knoblauch raised his target to $178 from $167 while reiterating Overweight. His thesis rests on four pillars.
On capacity, CoreWeave energized roughly 450 MW in a single quarter, more than double the total capacity of its next closest specialist competitor, and management lifted its year-end capacity target by another 150 MW. On revenue and margins, quarterly growth around 130% year over year with adjusted operating income up more than 80%. Adjusted EBITDA doubled to $1.51 billion at a 59% margin, and management guided full-year revenue to $12.4 billion to $13.2 billion with Q4 margins reaching the low teens.
Backlog visibility is the third pillar. Cantor estimates CoreWeave has locked in roughly 90% of its $30 billion ARR target for 2027, aided by more than $25 billion of net new customer commitments added in early Q3 2026. Fourth, demand is broadening beyond hyperscaler anchors, with shorter-duration, higher-margin GPU instances gaining traction. The $178 target reflects an 8.5x 2027 EV/EBITDA multiple, slightly lower than the prior 9.1x, offset by higher operating estimates.
Across the analyst pool, 36 analysts cover the name: 5 Strong Buy, 21 Buy, 9 Hold, 1 Sell, and 1 Strong Sell. Recent revisions have skewed higher.
How Nebius, IREN, and Applied Digital Stack Up
The AI cloud peer group has diverged. Nebius has ripped higher, IREN has been steady, and Applied Digital sits with the widest analyst-implied gap.
Nebius Group (NASDAQ:NBIS | NBIS Price Prediction) trades at $259.20 after a 244.09% one-year run. The average target of $250.75 now sits slightly below the stock, implying about -3% from here. Ratings tilt bullish at 1 Strong Buy, 10 Buy, 5 Hold, and 1 Strong Sell, but price has caught up to consensus.
IREN (NASDAQ:IREN) trades at $43.67, up 144.92% over the past year, backed by a $3.4 billion five-year NVIDIA AI Cloud contract. The 15-analyst average target of $81.73 implies about 87% upside, with a Buy-heavy skew.
Applied Digital (NASDAQ:APLD) trades at $31.09 and has doubled over the past year. Its $74.23 average target across 11 analysts (2 Strong Buy, 8 Buy, 1 Hold) points to roughly 139% upside, the widest gap in the group.
Applied Digital has the largest analyst-implied upside, but CoreWeave’s Cantor case combines a similarly bullish target with larger scale, backlog, and current revenue.
Where the Numbers Point
CoreWeave trades at $107.73 against Cantor’s $178 target and a broader analyst average of $138.37, implying roughly 65% upside to the Cantor bull case and about 28% to consensus. The stock has climbed 50.44% year to date, well ahead of the S&P 500’s 13.28%, yet remains 27.58% below where it traded a year ago.
Valuation carries real risk. The company is unprofitable, with a net margin of -22.74%, debt-to-equity of 8.94, and net debt to EBITDA of 10.75. Reddit chatter around the earnings call skewed bearish, with sentiment scores between 22 and 45.
My Take: A Setup for Believers in the Backlog
The bull case works if the $104 billion backlog converts as scheduled and margins keep inflecting into Q4. That path to Cantor’s $178 target: capacity comes online, higher-priced Vera Rubin SKUs ramp, managed inference ARR scales from $100 million toward $250 million by year-end, and free cash flow turns positive as CapEx normalizes past 2026.
The bear case takes over if capital markets tighten. With CapEx guided to $35 billion to $39 billion for the year and interest expense already north of $600 million a quarter, any disruption to debt access or delay in customer power delivery could turn the leverage story into a trap. Securities fraud litigation sits in the background as a reminder that execution slippage has consequences.
On balance, I lean cautiously constructive. The Cantor bull case still carries execution risk, yet contracted backlog, energized capacity, and Q2 operating leverage make the 65% gap look more like a real setup than a value trap.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks